- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Diabetes
The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.
Co-Occuring Gestational Diabetes, Hypertension Linked with Doubling of Future Cardiovascular Risk
November 28, 2022
An analysis of more than 800k women in Canada provides insight into the apparent increase in risk of incident cardiovascular disease associated with co-occurrence of gestational diabetes and gestational hypertensive disorders in pregnant women.
Endocrine Month in Review: November 2022
November 26, 2022
The November 2022 endocrine month in review features coverage of the FDA’s approval of teplizumab, new data related to use of GLP-1 receptor agonists, and a trio of stories on topics pertaining to diabetes technology.
Incorporating Weight Training Into Physical Activity Regimen Linked to Reduced Mortality in Type 2 Diabetes
November 25, 2022
An analysis of data from the Health Professionals Follow-Up Study suggests incorporating weight training into physical activity regimens was associated with reduced mortality in patients with or without type 2 diabetes, with the association in those without diabetes present even after adjustment for aerobic activity levels.
Universal Screening for Adults 40-70 Years Old Could Identify Most Diabetes Cases 2 Years Earlier
November 23, 2022
Using data from the UK Biobank study, a team of investigators from the University of Exeter determined undiagnosed cases of type 2 diabetes could be identified more than 2 years earlier if universal screening programs were implemented for middle-aged adults.
European Study Links Antibiotic Exposure to Increased Risk of Type 2 Diabetes Later in Life
November 22, 2022
An analysis of data from a pair of studies examining cardiovascular risk in individuals from countries in Europe provides insight into an apparent increase in the likelihood of developing type 2 diabetes among people with a history of exposure to antibiotics.
People with Type 2 Diabetes at Greater Risk of Having Advanced Stage Cancer at Time of Diagnosis
November 19, 2022
An analysis of data from the EPIC study provides insight into an apparent increase in risk of having an advanced stage cancer at time of diagnosis for patients with cardiometabolic diseases compared to their counterparts without cardiometabolic diseases.
Key Takeaways from the ADA-KDIGO Consensus Statement on CKD, with Kim Zuber, MS, PA-C, and Jane Davis, DNP
November 17, 2022
Kim Zuber, MS, PA-C, and Jane Davis, DNP, provide perspective on the recent consensus statement on management of chronic kidney disease from the American Diabetes Association and the Kidney Disease Improving Global Outcomes group.
Study Details Predictors of Diabetes in People with Chronic Pancreatitis
November 16, 2022
A Cedars-Sinai-led analysis of data from the PROCEED study provides insight into risk factors and clinical predictors of diabetes among a cohort of adult patients with chronic pancreatitis.
The Possibility of Using Lipid Biomarkers to Predict Diabetic Neuropathy, with Gregory Weiss, MD
November 08, 2022
In this column, Gregory Weiss, MD, reviews recent data suggesting lipid biomarkers could be used to identify patients at increased risk of developing diabetic neuropathy later in life.
Metformin Pulling Double Duty as Emerging Therapy in AFib, with Gregory Weiss, MD
November 05, 2022
In this column, Gregory Weiss, MD, provides perspective on a recent study providing evidence in support of metformin as a potential therapeutic option for treatment of atrial fibrillation.